Organization: Government of Canada

How Canada can upskill its workforce after the COVID-19 pandemic

The disruption caused by the COVID-19 pandemic has created the perfect conditions to consider new, innovative approaches to rapidly upskill and redeploy domestic talent, say AJ Tibando and Arvind Gupta, the executive director and the CEO of Palette Skills, respectively, in an opinion piece.

Will Canada’s new investments in commercialization pay off?

Too often, the products of science and research done within Canada’s borders ends up being sold or commercialized elsewhere. But there’s been a strong effort in the last few months to attempt to reverse the decades-long trend, writes Research Money’s managing editor Sebastian Leck.

The Short Report – May 19, 2021: Ottawa injects $200 million into domestic vaccine manufacturing capacity, CAN Health Network project extended, nuclear leaders prepare CANDU reactors for decommissioning, and more

Resilience Biotechnologies receives significant funding to produce made-in-Canada vaccines, Ottawa extends the CAN Health Network project in Ontario by one year with a $3.25-million investment, Canada’s nuclear leaders collaborate on the decommissioning process, and more.